Analysis of the Breast Cancer Mortality Rate in Portugal Over a Decade: Spatiotemporal Clustering Analysis

Autor: Inês Afonso Gomes, Carla Nunes

Publikováno v: Acta Médica Portuguesa, Vol 33, Iss 5 (2020)

Introduction: Breast cancer is the first cause of cancer-related death in Portuguese women. This study aimed to characterize female breast cancer mortality in Portugal in the period between 2002 and 2013, with a special focus on spatiotemporal patter

Externí odkaz: https://doaj.org/article/01ead160cdc34a248351bfa05353e6d1

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Autor: Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Carolyn Morris, Zohal Nabi, Elinor Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M Bliss, John R Yarnold, Anne Armstrong, Judith Bliss, David Bloomfield, Jo Bowen, Murray Brunt, Hannah Chantler, Charlotte Coles, Ellen Donovan, Andy Goodman, Susan Griffin, Jo Haviland, Penny Hopwood, Anna Kirby, Julie Kirk, Cliona Kirwan, Marjory MacLennan, Mark Sculphur, Judith Sinclair, Mark Sydenham, Jean Tremlett, Karen Venables, Duncan Wheatley, John Yarnold

Publikováno v: Lancet (London, England)
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6

BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after pri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e395035946033bfb3c8db03e2d044a

Mortalidad por Cáncer de Mama en Mujeres en Alagoas nel Periodo de 2001 a 2016: Análisis de Tendencias y Distribución Espacial

Autor: de Souza Lôbo, Jéssica Luzia, Costa Silva, Monalisa Lídia, Barbosa Vieira Tomé, Thaysa Kelly, Dornels Freire de Souza, Carlos

Publikováno v: Revista Brasileira de Cancerologia; Vol. 66 No. 1 (2020): Jan./Feb./Mar.; e-09656
Revista Brasileira de Cancerologia; Vol. 66 Núm. 1 (2020): enero/feb./marzo; e-09656
Revista Brasileira de Cancerologia; v. 66 n. 1 (2020): jan./fev.mar.; e-09656
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA

Introduction: Breast cancer is the neoplasm that causes more deaths in the female population worldwide and in Brazil. Objective: To analyze the epidemiological profile, trend and spatial distribution of female breast cancer mortality in Alagoas from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::ef9b028db20ba7de14e9d51df7bf8dac
https://rbc.inca.gov.br/index.php/revista/article/view/656

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Autor: Fatima, Cardoso, Laura J, van't Veer, Jan, Bogaerts, Leen, Slaets, Giuseppe, Viale, Suzette, Delaloge, Jean-Yves, Pierga, Etienne, Brain, Sylvain, Causeret, Mauro, DeLorenzi, Annuska M, Glas, Vassilis, Golfinopoulos, Theodora, Goulioti, Susan, Knox, Erika, Matos, Bart, Meulemans, Peter A, Neijenhuis, Ulrike, Nitz, Rodolfo, Passalacqua, Peter, Ravdin, Isabel T, Rubio, Mahasti, Saghatchian, Tineke J, Smilde, Christos, Sotiriou, Lisette, Stork, Carolyn, Straehle, Geraldine, Thomas, Alastair M, Thompson, Jacobus M, van der Hoeven, Peter, Vuylsteke, René, Bernards, Konstantinos, Tryfonidis, Emiel, Rutgers, Martine, Piccart, Marc, Buyse

Publikováno v: The New England journal of medicine, vol. 375, no. 8, pp. 717-729

BACKGROUND: The 70-gene signature test (MammaPrint) has been shown to improve prediction of clinical outcome in women with early-stage breast cancer. We sought to provide prospective evidence of the clinical utility of the addition of the 70-gene sig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51178c2cd69f6819a624c99d576e33d5
https://doi.org/10.1056/nejmoa1602253